Out-of-Pocket Cost Letters

Featured Letters

Below are some of our featured letters on Out-of-Pocket Costs that highlight our recent work and victories.

To see all of our letters on this topic, scroll down to the archive section.

 
NPF advocates walking in a legislative building.

Federal Out-of-Pocket Costs

NPF Joins 33 Patient Organizations Regarding the Supreme Court’s Ruling on the ACA.

Read more

Federal Out-of-Pocket Costs

NPF adds name to colalition letter urging Congress to take action on out-of-pocket costs in Medicare Part D.

Read more

Federal Out-of-Pocket Costs

NPF joins coalition letter asking HHS to reconsider cost sharing provision in 2021 Notice of Benefit & Payment Parameters under COVID-19 Circumstances.

Read more

State Out-of-Pocket Costs

NPF submits letter of support for Arizona copay accumulator bill HB 2166 to Governor Ducey.

Read more

State Out-of-Pocket Costs

NPF submits letter in support of Washington insulin cap bill SB 6087 to Senate Health & Long Term Care Committee.

Read more

State Out-of-Pocket Costs

NPF adds name to coalition letter in support of protections for surprise medical bills (HB 1862) to Pennsylvania Full House.

Read more

Letter Archive

Federal Letters on Out-of-Pocket Costs

2021

  • 06/17/2021 - NPF Joins 33 Patient Organizations Regarding the Supreme Court’s Ruling on the ACA
    Read more

2020

● 12/16/2020 - NPF Joins Coalition Statement Calling on Congress to Permanently End Surprise Medical Billing

Read more

● 12/04/2020 - NPF Joins Coalition Letter to Congressional Leadership Regarding Surprise Medical Billing

Read more

● 07/20/2020 - NPF Adds Name to Coalition Letter Urging Congress to Take Action on Out-of-Pocket Costs in Medicare Part D

Read more

● 05/21/2020 - NPF Adds Name to Coalition Letter Calling on Congress to End Surprise Medical Billing

Read more

● 05/21/2020 - NPF Adds Name to Coalition Letter Asking President Trump to End Surprise Medical Billing

Read more

● 05/05/2020 - NPF Joins Coalition Letter Asking HHS to Reconsider Cost Sharing Provision in 2021 Notice of Benefit & Payment Parameters Under COVID-19 Circumstances

Read more

● 04/06/2020 - NPF Submits Comments in Response to the 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule

Read more

● 03/02/2020 - NPF Adds Name to Coalition Letter to HHS Re: 2021 Notice of Benefit & Payment Parameters Proposed Rule

Read more

● 02/11/2020 - NPF Adds Name to Coalition Letter in Support of the Ban Surprise Billing Act

Read more

● 01/13/2020 - NPF Submits Comment Letter on Wisconsin Step Therapy Rulemaking Process

Read more

● 01/13/2020 - NPF Adds Name to Coalition Letter Urging Congress to Reverse Increase in Medicare Part D Out-of-Pocket Costs in 2020

Read more

2019

● 10/29/19 - NPF Adds Name to Coalition Letter to Speaker Pelosi Thanking Her for Supporting an Out-of-Pocket Cap and 'Smoothing' in Medicare Part D

Read more

● 10/18/19 - NPF Submits Comments in Response to ICER Proposed Updates to 2020 Value Assessment Framework

Read more

● 09/10/19 - NPF Adds Name to Letter Supporting the Prescription Drug Pricing Reform Act of 2019

Read more

● 07/24/19 - NPF Joins Coalition Letter to House Ways and Means Committee in Support of Medicare Part D Reform

Read more

● 06/06/19 - NPF Submits Letter in Support of S. 1384, the Prescription Drug Rebate Reform Act of 2019

Read more

● 06/06/19 - NPF Joins Coalition Letter to Congress in Support of Medicare Part D Reform

Read more

● 04/08/19 - NPF Submits Letter to HHS in Response to Department of Health and Human Services (HHS) Removal of Safe Harbor Protections for Rebates Involving Pharmaceuticals

Read more

● 02/19/19 - NPF Submits Comments in Response to HHS Notice of Benefit and Payment Parameters for 2020

Read more

● 01/25/19 - NPF Submits Comments in Response to the 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule

Read more

State Letters on Out-of-Pocket Costs

2021

● 02/10/2020 - Maryland All Copays Count Coalition Submits Letter to Senate Finance Committee in Support of SB 290

Read more

● 02/10/2020 - NPF Submits Letter to Maryland Senate Finance Committee in Support of SB 290

Read more

● 01/20/2020 - NPF Joins Maryland All Copays Count Coalition Letter in Support of HB 167

Read more

● 01/20/2020 - NPF Submits Letter in Support of Maryland All Copays Count Legislation

Read more

2020

● 06/15/2020 - NPF Joins Coalition in Urging New York Senators to Support Copay Accumulator Protections (S6303/A8246)

Read more

● 06/15/2020 - NPF Joins Coalition in Urging New York Assembly Members to Support Copay Accumulator Protections (S6303/A8246)

Read more

● 06/01/2020 - NPF Submits Testimony in Favor of Ohio Copay Accumulator Protections (HB 469) to House Health Committee

Read more

● 05/21/2020 - NPF Adds Name to Coalition Letter in Support of Protections for Surprise Medical Bills (HB 1862) to Pennsylvania Full House

Read more

● 04/09/2020 - NPF Adds Name to Kentucky Coalition Letter in Support of an Executive Order to Provide Copay Accumulator Protections During COVID-19

Read more

● 04/09/2020 - NPF Joins Others in Expressing Support to Rep. Bentley for Inclusion of Kentucky HB 72 to Address Copay Accumulators in COVID-19 Executive Order

Read more

● 04/07/2020 - NPF Adds Name to Ohio Coalition Letter in Support of an Executive Order to Provide Copay Accumulator Protections During COVID-19

Read more

● 04/07/2020 - NPF Joins Others in Expressing Support to Rep. Manchester for Inclusion of Ohio HB 469 to Address Copay Accumulators in COVID-19 Executive Order

Read more

● 03/27/2020 - NPF Submits Letter Commenting on California Health Benefits Review Program Analysis of AB 2203 Insulin Cost Sharing

Read more

● 03/11/2020 - NPF Adds Name to Kentucky Coalition Letter in Support of HB 72 to Protect Patients From Copay Accumulators

Read more

● 03/04/2020 - NPF Submits Letter in Support of Kentucky Copay Accumulator Bill HB 72 to House Banking & Insurance Committee

Read more

● 02/25/2020 - NPF Submits Letter in Support of Washington Insulin Cap Bill SB 6087 to Senate Health & Long Term Care Committee

Read more

● 02/18/2020 - NPF Submits Letter in Support of Nebraska Insulin Cap Bills LB 970 and LB 949 to Banking Commerce & Insurance Committee

Read more

● 02/06/2020 - NPF Submits Letter in Support of Maryland Insulin Cap Bill HB 134 to Government Operations Committee

Read more

2019

● 04/09/19 - NPF Submits Letter of Support for Arizona Copay Accumulator Bill HB 2166 to Governor Ducey

Read more

● 03/25/19 - NPF Submits Letter of Support for West Virginia Copay Accumulator Bill HB 2770 for Governor Justice

Read more

● 02/26/19 - NPF Submits Letter of Support for Oregon Copay Only Plans Bill HB 2799 to House Committee on Healthcare

Read more

● 02/25/19 - NPF Submits Letter of Support for Connecticut Copay Accumulator Bill SB 30 to Joint Committee on Insurance and Real Estate

Read more

Advocates standing together in a legislative building.

Letter Archive

Access our full collection of advocacy letters.

Return to the Letter Archive
A woman sits with other participants as they listen to a training on advocacy.

Utilization Management

Prior authorization and step therapy are designed to manage costs but can stand between patients and the care they need. NPF advocacy works to make these processes more transparent and patient friendly.

Letters on Utilization Management
Advocates meet with a politician in an office.

Other Policy Areas

Whether it’s value-based care, telehealth, or protections for pre-existing conditions, NPF advocacy is weighing in to ensure the psoriatic disease community is heard.

Letters on Other Policy Areas

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.